Cross-disciplinary HIV Integrated Mental Health Support Intervention

Overview

The proposed project seeks to develop and test an intervention to improve engagement in HIV and mental health care for young Black gay, bisexual and other men who have sex with men (YB-GBMSM) in Ryan White clinics.

Full Title of Study: “Cross-disciplinary HIV Integrated Mental Health Support (CHIMES) Intervention”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Sequential Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 1, 2023

Detailed Description

Young Black gay, bisexual and other men who have sex with men (YB-GBMSM) are disproportionately impacted by HIV, with suboptimal rates of engagement across the HIV Continuum of Care (HIV-CoC). Mental health (MH) comorbidities contribute to poor HIV care engagement for many YB-GBMSM; however, effective treatment for these conditions is hindered by barriers including logistical challenges, medical mistrust, and MH stigma. The Ryan White Care act supports integration of HIV and MH services; however, preliminary studies demonstrate low rates of MH referrals and MH care engagement among YB-GBMSM living with HIV, even in these ostensibly integrated care settings. The objective of this study is to develop and implement CHIMES (Cross-disciplinary HIV Integrated with Mental Health Support), a clinic- and provider-level intervention to improve HIV-MH care integration and MH care engagement among YB-GBMSM attending Ryan White clinics. The rationale for this study is that efforts to improve integration of services, particularly if they are culturally tailored, are likely to increase MH and HIV care engagement for YB-GBMSM. The proposed study will pursue two specific aims: (1) to develop the CHIMES intervention; and (2) to conduct a hybrid type 2 implementation-effectiveness pilot trial of CHIMES in two Health Resources and Services Administration (HRSA)/Ryan White-funded clinics in Atlanta, Georgia – a city in the heart of the Southern HIV epidemic. For the first aim, the researchers will work collaboratively with provider and patient stakeholders, adapt existing evidence-based interventions, and build on formative data to refine intervention content, informed by the Capability- Opportunity-Motivation-Behavior (COM-B) Model. For the second aim, the researchers will implement CHIMES in the two clinic settings and conduct a mixed-methods assessment in which continuous data collection informed by the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework will be used to evaluate effectiveness and implementation processes. The effectiveness of the CHIMES intervention will be measured by change in HIV and MH care engagement before, during, and after CHIMES implementation. The researchers will abstract clinic-level aggregate data to characterize change in HIV-CoC and MH care engagement outcomes for YB-GBMSM.

Interventions

  • Behavioral: CHIMES Intervention
    • There are six components to the intervention: Posters and other print materials to prompt providers and patients to discuss MH care engagement. Brief verbal scripts to help HIV providers facilitate patient MH engagement and discuss barriers to MH utilization. Expanded MH screening procedures, including at initial intake. Case management, emphasizing MH care engagement. Interactive trainings for all HIV providers on MH needs, screening/treatment, and barriers to MH service utilization specific to YB-GBMSM. Regular case review meetings.
  • Behavioral: Standard of Care
    • The standard of care practices of referring patients to mental health services of the clinic during Months 1 – 12 of the study.

Arms, Groups and Cohorts

  • Active Comparator: Clinic Patients During the Pre-implementation Period
    • Patients visiting one of the study clinics prior to implementation of the CHIMES intervention. The Baseline time period consists of study Months 1 – 12. Data are retroactively abstracted from medical records of patients who had clinic visits that occurred between January 1, 2019 and December 31, 2019.
  • Experimental: Clinic Patients During the Implementation Period
    • Patients visiting one of the study clinics during the Implementation period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 13 – 27.
  • Experimental: Clinic Patients During the Maintenance Period
    • Patients visiting one of the study clinics during the Maintenance period of the CHIMES intervention. Data will be abstracted from medical records of visits that occur during study Months 28 – 33.

Clinical Trial Outcome Measures

Primary Measures

  • Number of Mental Health Visits
    • Time Frame: Baseline (Months 1-12) up to Month 33
    • The number of mental health visits by clinic patients during each study time period.
  • Percentage of Mental Health Visits by YB-GBMSM
    • Time Frame: Baseline (Months 1-12) up to Month 33
    • The percentage of mental health visits by YB-GBMSM clinic patients during each study time period.
  • Number of Patients Attending Two HIV Care Visits
    • Time Frame: Baseline (Months 1-12) up to Month 33
    • The number of patients who come to two HIV Care visits in a 12 month period, during each study time period.
  • Number of Patients with HIV RNA Viral Suppression
    • Time Frame: Baseline (Months 1-12) up to Month 33
    • The number of patients with HIV RNA less than 200 Copies, during each study time period.
  • Number of Mental Health Care Referrals
    • Time Frame: Baseline (Months 1-12) up to Month 33
    • The number of referrals to mental health care during a 12 month period, during each study time period.
  • Percentage of Mental Health Referrals for YB-GBMSM
    • Time Frame: Baseline (Months 1-12) up to Month 33
    • The percentage of mental health referrals by YB-GBMSM clinic patients during each study time period.

Participating in This Clinical Trial

Inclusion Criteria

  • young Black gay, bisexual and other men who have sex with men (YB-GBMSM) living with HIV – patient at Grady Health System Infectious Disease Program or Emory University Hospital Midtown Infectious Disease Clinic Exclusion Criteria:

  • none

Gender Eligibility: Male

Minimum Age: 18 Years

Maximum Age: 29 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Emory University
  • Collaborator
    • National Institute of Mental Health (NIMH)
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sophia Hussen, Associate Professor – Emory University
  • Overall Official(s)
    • Sophia Hussen, MD, MPH, Principal Investigator, Emory University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.